TOCILIZUMAB

More in TOCILIZUMAB

• Centre expedited supply of essential drugs for COVID : Mandaviya

  All major drugs required for the management of COVID-19 was regularly monitored through weekly surveys of retail pharmacies

  

• Remdesivir, tocilizumab helped patients: Study

  ​The survival rate in patients receiving either or both the drugs was 64%; it dropped to 34% among those who did not get any of the two. In the group that benefitted, the rate of discharge among those given only remdesivir was 66%, for those who got only tocilizumab it was 80%, and 47% among those given both the drugs combined.

  

• Govt plans nat’l stockpile of life-saving drugs

  The government is in discussions with the pharma and medical devices industry to create a “national stockpile” of life-saving drugs and vital equipment to combat the third Covid wave.

  

• US FDA okays arthritis drug for treatment of Covid-19

  Under the EUA, the drug can be administered only to hospitalised adults and pediatric patients (2 years of age and older), receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

  

• NPPA directs manufacturers, marketing cos to pass on benefit of reduced GST to customers

  Manufacturers can ensure price compliance at retailer level through revised price list, the authority said in an office memorandum issued Wednesday.

  

• Kolkata hospital part of Covid drug trial

  ​​Peerless Hospital will be among 10 Indian hospitals where Tocilizumab’s Indian version will undergo ‘therapeutic equivalent trial’.

  

• Key drugs, steroids in short supply; input costs surge

  India is facing a shortage of certain antibiotics, key steroids, anti-fungal drugs, life-saving medicines, vitamins and even commonly used paracetamol, amid a severe second wave of Covid-19.

  

• Govt monitoring supply of various Covid-19 treatment drugs, says minister

  In an official statement, the minister noted that all drugs used in the management of Covid-19 were now available in India by ramping up production and increasing the imports.

  

• Plasma therapy dropped from ICMR Covid-19 treatment protocols

  As per the previous advisory, Remdesivir, Tocilizumab (off label) and Convalescent plasma (Off label) were used for treatment of Covid-19 patients.

  

• Will antibody cocktail help, HC asks Centre

  One of the largest pharma companies has told the Delhi high court that a new “antibody cocktail” is on the anvil, which can replace Tocilizumab, a drug used in severe Covid 19 cases but in short supply.

  

• Mumbai: Cipla files complaint against e-sale of fake Covid medicines

  On Wednesday, Cipla Pharma filed a complaint with the state cyber cell alleging that fraudsters impersonating as its distributors were using the company’s logo and despatching fake Covid medicines online. The state cyber cell has filed an FIR.